Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomomi Noguchi

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Bioorganic & Medicinal Chemistry Letters|July 28, 2006
Tubulin polymerization inhibitors with a fluorinated phthalimide skeleton derived from thalidomideTomonori Yanagawa, Tomomi Noguchi, Hiroyuki Miyachi, et al.
Bioorganic & Medicinal Chemistry Letters|June 7, 2005
Cell differentiation inducers derived from thalidomideTomomi Noguchi, Hiroyuki Miyachi, Ryohei Katayama, et al.
Chemical & Pharmaceutical Bulletin|December 2, 2006
Mono- and dihydroxylated metabolites of thalidomide: synthesis and TNF-alpha production-inhibitory activityTakanori Nakamura, Tomomi Noguchi, Hisayoshi Kobayashi, et al.
Bioorganic & Medicinal Chemistry|April 6, 2005
Design and synthesis of subtype-selective cyclooxygenase (COX) inhibitors derived from thalidomideHiroko Sano, Tomomi Noguchi, Aya Tanatani, et al.
Chemical & Pharmaceutical Bulletin|August 12, 2004
N-phenylphthalimide-type cyclooxygenase (COX) inhibitors derived from thalidomide: substituent effects on subtype selectivityHiroko Sano, Tomomi Noguchi, Aya Tanatani, et al.
Bioorganic & Medicinal Chemistry Letters|March 4, 2006
Anti-angiogenic activity of basic-type, selective cyclooxygenase (COX)-1 inhibitorsHiroko Sano, Tomomi Noguchi, Atsushi Miyajima, et al.
Bioorganic & Medicinal Chemistry Letters|October 5, 2010
Novel selective anti-androgens with a diphenylpentane skeletonKeisuke Maruyama, Tomomi Noguchi-Yachide, Kazuyuki Sugita, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2007
Liver X receptor antagonists with a phthalimide skeleton derived from thalidomide-related glucosidase inhibitorsTomomi Noguchi-Yachide, Atsushi Aoyama, Makoto Makishima, et al.
Bioorganic & Medicinal Chemistry|August 12, 2008
Antiproliferative and apoptosis-inducing activities of alkyl gallate and gallamide derivatives related to (-)-epigallocatechin gallateKosuke Dodo, Taro Minato, Tomomi Noguchi-Yachide, et al.
Bioorganic & Medicinal Chemistry|May 16, 2022
Design, synthesis and structure-activity relationship of 4-(1,1,1,3,3,3-hexafluoro-2-hydroxyisoprop-2-yl)phenylsilane derivatives as liver X receptor agonistsNao Namba, Tomomi Noguchi-Yachide, Yuichiro Matsumoto, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Bioorganic & Medicinal Chemistry Letters|July 28, 2006
Tubulin polymerization inhibitors with a fluorinated phthalimide skeleton derived from thalidomideTomonori Yanagawa, Tomomi Noguchi, Hiroyuki Miyachi, et al.
Bioorganic & Medicinal Chemistry Letters|June 7, 2005
Cell differentiation inducers derived from thalidomideTomomi Noguchi, Hiroyuki Miyachi, Ryohei Katayama, et al.
Chemical & Pharmaceutical Bulletin|December 2, 2006
Mono- and dihydroxylated metabolites of thalidomide: synthesis and TNF-alpha production-inhibitory activityTakanori Nakamura, Tomomi Noguchi, Hisayoshi Kobayashi, et al.
Bioorganic & Medicinal Chemistry|April 6, 2005
Design and synthesis of subtype-selective cyclooxygenase (COX) inhibitors derived from thalidomideHiroko Sano, Tomomi Noguchi, Aya Tanatani, et al.
Chemical & Pharmaceutical Bulletin|August 12, 2004
N-phenylphthalimide-type cyclooxygenase (COX) inhibitors derived from thalidomide: substituent effects on subtype selectivityHiroko Sano, Tomomi Noguchi, Aya Tanatani, et al.
Bioorganic & Medicinal Chemistry Letters|March 4, 2006
Anti-angiogenic activity of basic-type, selective cyclooxygenase (COX)-1 inhibitorsHiroko Sano, Tomomi Noguchi, Atsushi Miyajima, et al.
Bioorganic & Medicinal Chemistry Letters|October 5, 2010
Novel selective anti-androgens with a diphenylpentane skeletonKeisuke Maruyama, Tomomi Noguchi-Yachide, Kazuyuki Sugita, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2007
Liver X receptor antagonists with a phthalimide skeleton derived from thalidomide-related glucosidase inhibitorsTomomi Noguchi-Yachide, Atsushi Aoyama, Makoto Makishima, et al.
Bioorganic & Medicinal Chemistry|August 12, 2008
Antiproliferative and apoptosis-inducing activities of alkyl gallate and gallamide derivatives related to (-)-epigallocatechin gallateKosuke Dodo, Taro Minato, Tomomi Noguchi-Yachide, et al.
Bioorganic & Medicinal Chemistry|May 16, 2022
Design, synthesis and structure-activity relationship of 4-(1,1,1,3,3,3-hexafluoro-2-hydroxyisoprop-2-yl)phenylsilane derivatives as liver X receptor agonistsNao Namba, Tomomi Noguchi-Yachide, Yuichiro Matsumoto, et al.
Pageof 5